BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

The Week in Review: Shaanxi Bicon Pharma Raises $250 Million


3/5/2012 9:00:37 AM

March 3, 2012 -- Shaanxi Bicon Pharma raised $250 million from private equity fund PAG Asia Capital; MBK Partners, a PE group based in Korea, sold its 77% interest in Luye Pharma Group to three other PE firms; C3 Jian, a dental spinoff from UCLA with a China subsidiary, announced a new $30 million funding round; Shijiazhuang Yiling Pharma revealed plans to invest $22 million into innovative collaborations with other China pharmas; Tibet Pharma will go private at $3 per share; Cumberland Pharma of the US out-licensed the China rights for two of its drugs to Harbin Gloria Pharma; and Shanghai Pharma will collaborate with Guangdong Province’s CDC on cold chain drug distribution. More details….

Stock Symbols: (SHE: 002603) (NSDQ: TBET) (NSDQ: CPIX) (SHE: 002437) (SHA: 601607; HK: 02607)


Read at ChinaBio Today


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->